PUBLIC COMPANY
saveHalda Therapeutics LLC
updated 5mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- From RAS rivalries to leaked cancer vaccine readouts, ESMO brought the data dramaEvery ESMO conference is eventful, but the drama kicked into gear earlier than expected this year when the eagerly anticipated phase 3 data for Moderna and Merck & Co.’s cancer vaccine were leaked…fiercebiotech · 18d ago
- ESMO 2026: J&J delivers ‘immaculate’ early data for prostate cancer drug from HaldaJNJ-6143, which came from Johnson & Johnson’s $3 billion takeover of Halda Therapeutics in 2025, showed a 75% overall response rate in the Phase 1 readout.biospace · 19d ago
- ESMO: J&J exec says RIPTAC readout is ‘best data we’ve ever seen’ for a prostate cancer drugA year after paying over $3 billion for Halda Therapeutics, Johnson & Johnson has unveiled the first data from its shiny new RIPTAC pipeline it believes could sustain its leading role in prostate c…fiercebiotech · 20d ago
- STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and moreJohnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancerstat · 4mo ago
comments(0)
5-min edit window · permanent after that